33 completed, 5 unknown, 4 not yet recruiting, 4 terminated. 51 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 51 | Completed 33, Unknown 5, Not yet recruiting 4, Terminated 4, Active not recruiting 3, Withdrawn 2 |
Follow Gels: new trials by email Literature Review of Gels trials Research Report on Gels
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuropathy Topical Lidocaine 2% Gel, Duloxetine (60 MG) - Painful Diabetic Neuropathy (PDN), Diabetic Neuropathies | Phase 4 | Not yet recruiting | Wah Medical college , POF hospital | 80 | 2026-12-01 | 2026-09-02 |
| Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel - Acne Vulgaris | Phase 4 | Not yet recruiting | Allied Hospital Faisalabad | 118 | 2026-11-01 | 2026-10-19 |
| Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition Transdermal estradiol, Standard of care - non hormonal - Menopause, Perimenopause | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 100 | 2026-11-01 | 2026-07-29 |
| Topical Methotrexate vs Minoxidil for Localized Alopecia Areata Methotrexate 1% Topical Gel, Minoxidil 5% Topical Spray - Alopecia Areata | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 268 | 2026-03-15 | 2026-03-10 |
| Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris Dapsone 7.5% gel, Vehicle gel - Acne Vulgaris | Phase 4 | Completed | Oya Helin Dundar | 100 | 2025-06-17 | 2026-05-22 |
| Brimonidine 0.33% for Rosacea-Related Facial Erythema Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic) | Phase 4 | Completed | Istanbul Training and Research Hospital | 45 | 2025-05-01 | 2026-02-24 |
| Pharmacokinetics of Transdermal Metronidazole Metronidazole 0.75% Topical Gel, Metronidazole 0.75% Topical Cream, Transdermal water loss measurement - Healthy | Phase 4 | Active not recruiting | University of Iowa | 24 | 2024-02-26 | 2026-10-16 |
| A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne Winlevi (clascoterone) 1% & Adapalene 0.3% gel - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 20 | 2023-11-15 | 2025-10-09 |
| Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial Aloe vera gel, Benzydamine Hydrochloride 0.15% Oral gel - Head and Neck Cancer Patients Treated With Radiotherapy | Phase 4 | Completed | October 6 University | 40 | 2023-06-01 | 2025-03-17 |
| Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full Face Ameluz 10% Topical Gel, Red Light PDT, Cryotherapy - Actinic Keratoses | Phase 4 | Active not recruiting | Psoriasis Treatment Center of Central New Jersey | 40 | 2023-05-03 | 2026-10-14 |
| A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp Tirbanibulin (Klisyri®) 10 mg/g ointment, Diclofenac Sodium 3% Gel - Keratosis, Actinic | Phase 4 | Active not recruiting | Almirall, S.A. | 447 | 2022-10-24 | 2025-02-11 |
| Pain Experience Using Lidocaine Adrenaline Tetracaine (LAT) Gel Versus Lidocaine Infiltration for Laceration Repair in Adults Lidocaine-Adrenaline-Tetracaine (LAT) Gel, Lidocaine infiltration - Lacerations, Wound Repair | Phase 4 | Completed | Vrije Universiteit Brussel | 70 | 2021-04-01 | 2026-03-18 |
| Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia Cetirizine, Minoxidil - Androgenetic Alopecia | Phase 4 | Unknown | Assiut University | 60 | 2020-06-01 | 2020-03-04 |
| Comparison of 2 Application Techniques for LET Gel Used Prior to Simple Laceration Repair LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (1 application), LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (3 applications) - LET, Laceration of Skin | Phase 4 | Completed | Children's Hospital of Orange County | 48 | 2019-06-19 | 2020-09-02 |
| Palatal Wound Healing Evaluation After Application of Platelet Rich Fibrin Versus 0.2% Hyaluronic Acid Dressings hyaluronic acid (Gengiegel 0.2% oral gel ), Platelet rich fibrin, Gel foam - Free Gingival Graft | Phase 4 | Completed | Ain Shams University | 30 | 2019-02-01 | 2020-05-15 |
| Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients Zinc gluconate, Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo], Placebo - Acne Vulgaris | Phase 4 | Completed | East Avenue Medical Center, Philippines | 23 | 2018-12-21 | 2022-05-11 |
| Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea Bromonide 0.33% gel, Intense Pulsed Light (M22) - Rosacea | Phase 4 | Withdrawn | Rabin Medical Center | 2018-12-01 | 2022-10-31 | |
| Topical Metronidazole vs Control in Reducing Periodontal Pockets in a Split Mouth Clinical Trial Root scaling, Topical Gel - Periodontal Disease, Periodontal Inflammation | Phase 4 | Completed | University of Salamanca | 20 | 2018-10-10 | 2025-07-24 |
| Acceptance and Preference of Lidocaine Gel Compared to Injection Anesthesia After Non Surgical Periodontal Treatment Lidocaine Hydrochloride 1% Gel, Articaine hydrochloride/epinephrine (adrenaline) hydrochloride - Periodontitis | Phase 4 | Completed | Chemische Fabrik Kreussler & CO GmbH | 94 | 2017-12-05 | 2018-12-20 |
| Comparison of Two Application Techniques for LET Gel LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel - Lacerations, Pain, Procedural | Phase 4 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 48 | 2017-05-22 | 2021-02-18 |
Showing 20 of 51. Sign in to see all of them.
Acne Vulgaris (21) · Rosacea (4) · Hypogonadism (2) · Keratosis, Actinic (2) · Lacerations (2) · Pain (2) · Periodontitis (2) · Skin Manifestations (2) · Agnosia (1) · Alopecia (1) · Alopecia Areata (1) · Depression (1) · Dermatitis Herpetiformis (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Neuropathies (1)
Galderma R&D (7) · Stiefel, a GSK Company (3) · Derm Research, PLLC (2) · GlaxoSmithKline (2) · Zeichner, Joshua, M.D. (2) · Ain Shams University (1) · All India Institute of Medical Sciences, Bhubaneswar (1) · Allergan (1) · Allied Hospital Faisalabad (1) · Almirall, S.A. (1) · Assiut University (1) · Boston Medical Center (1) · Callender Center for Clinical Research (1) · Chemische Fabrik Kreussler & CO GmbH (1) · Children's Hospital of Orange County (1)
United States (26) · Germany (5) · Canada (4) · Egypt (3) · Spain (2) · Turkey (Türkiye) (2) · Belgium (1) · Brazil (1) · Denmark (1) · France (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Pakistan (1)
Ronald W Gottschalk, MD (4) · Adelaide Hebert, MD (1) · Alan Fleischer, MD (1) · Andrea Zaenglein, MD (1) · Assi Levi, Dr. (1) · Ayse Esra Koku Aksu, MD, Prof. (1) · Boni Elewski, MD (1) · Brandi D Newby, BScPharm (1) · Charles Lynde, MD (1) · David Kaplan, MD (1)
PMID 11488820, PMID 12095065, PMID 12553848, PMID 12839559, PMID 15483476, PMID 16340529, PMID 17056383, PMID 17061223, PMID 17620596, PMID 17891002, PMID 18249468, PMID 18472984, PMID 18812132, PMID 18996225, PMID 19205490, PMID 19376456, PMID 19439902, PMID 19898665, PMID 20213916, PMID 20592293, PMID 21102369, PMID 21178659, PMID 21607190, PMID 21697501, PMID 22282296, PMID 22385260, PMID 23292288, PMID 23652892, PMID 23730808, PMID 23839181, PMID 23928675, PMID 23964752, PMID 24059744, PMID 24089589, PMID 24171832, PMID 24317292, PMID 25315746, PMID 28913735, PMID 28950424, PMID 28981994, PMID 29656500, PMID 29846604, PMID 30501016, PMID 32231700, PMID 32346854, PMID 32853647, PMID 35100752, PMID 35318791, PMID 35492401, PMID 35796224
U01AG014369 (1)